AIA-900Analyzer, Product code 022930, 022930R The AIA-2000 analyzer and AIA-900 analyzer are c...

FDA Device Recall #Z-0600-2019 — Class II — September 28, 2018

Recall Summary

Recall Number Z-0600-2019
Classification Class II — Moderate risk
Date Initiated September 28, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Tosoh Bioscience Inc
Location Grove City, OH
Product Type Devices
Quantity 395

Product Description

AIA-900Analyzer, Product code 022930, 022930R The AIA-2000 analyzer and AIA-900 analyzer are capable of performing three methods of immunoassay: an immunoenzymetric (IEMA) or sandwich immunoassay, a competitive binding (EIA) immunoassay, and a two-step immunoenzymetric immunoassay.

Reason for Recall

Tosoh Bioscience has become aware of a potential issue with the AIA-900 and AIA-2000 analyzers that could result in slippage of the incubator unit contained within the system. If the tension of the timing belt is not adjusted correctly, it is possible for a misalignment that will result in a mechanical error. Tosoh has taken the required actions to inspect the tension of the timing belt during preventative maintenance and correct the instruments where this issue has been observed. If incubator slippage occurs, the unit will cease to function, and a system error will be reported. If this occurs, there may be a delay in testing and reporting patient test results. There have been no reports of injury related to this issue.

Distribution Pattern

US Nationwide distribution and International distribution to Colombia, Chile, Honduras, Cayman Islands, Panama, Costa Rica, Guatemala, Venezuela, Uruguay, Peru, and Ecuador.

Lot / Code Information

Affects all active analyzers. 022930, 022930R

Other Recalls from Tosoh Bioscience Inc

Recall # Classification Product Date
Z-2968-2020 Class II Tosoh Bioscience AIA-PACK BHCG Calibration Veri... Aug 7, 2020
Z-2967-2020 Class II Tosoh Bioscience AIA- PACK HCG Calibrator Set-I... Aug 7, 2020
Z-2423-2020 Class II AIA-900 Analyzer, Part no. 022930, UDI 04560189... May 22, 2020
Z-1420-2020 Class II AIA-360 Automated Immunoassay Analyzer, Product... Jan 10, 2020
Z-0675-2019 Class II ST AIA-PACK Homocysteine (HCY) is designed for ... Nov 30, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.